8 Major subsidiaries
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.12.2021 |
|
31.12.2020 |
||
|
|
|
|
|
|
|
|
|
|
|
Share of |
|
Share of |
||
|
Company name |
|
Domicile |
|
Purpose |
|
Currency |
|
Share capital/Nominal capital |
|
Capital |
Voting rights |
|
Capital |
Voting rights |
|
Fully consolidated companies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bellevue Group AG |
|
Küsnacht, Switzerland |
|
Holding |
|
CHF |
|
1 346 143 |
|
Parent company |
|
Parent company |
||
|
Bellevue Asset Management AG |
|
Küsnacht, Switzerland |
|
Asset Management |
|
CHF |
|
1 750 000 |
|
100% |
100% |
|
100% |
100% |
|
Bellevue Asset Management (Deutschland) GmbH |
|
Frankfurt am Main, Germany |
|
Asset Management |
|
EUR |
|
25 000 |
|
100% |
100% |
|
100% |
100% |
|
Bellevue Asset Management (UK) Limited |
|
London, UK |
|
Asset Management |
|
GBP |
|
50 000 |
|
100% |
100% |
|
100% |
100% |
|
Asset Management BaB N.V. |
|
Curaçao |
|
Asset Management |
|
USD |
|
6 001 |
|
100% |
100% |
|
100% |
100% |
|
Bellevue Research Inc. |
|
New York, USA |
|
Research |
|
USD |
|
100 |
|
100% |
100% |
|
100% |
100% |
|
BB Biotech Ventures GP |
|
Guernsey |
|
Investment Advisor |
|
GBP |
|
10 000 |
|
100% |
100% |
|
100% |
100% |
|
BB Pureos Bioventures GP Limited |
|
Guernsey |
|
Investment Advisor |
|
GBP |
|
60 000 |
|
99% |
99% |
|
99% |
99% |
|
StarCapital AG |
|
Oberursel, Germany |
|
Asset Management |
|
EUR |
|
540 000 |
|
100% |
100% |
|
100% |
100% |
|
adbodmer AG |
|
Horgen, Switzerland |
|
Investment Advisor |
|
CHF |
|
100 000 |
|
100% |
100% |
|
100% |
100% |
|
Bellevue Private Markets AG |
|
Küsnacht, Switzerland |
|
Holding |
|
CHF |
|
1 000 000 |
|
100% |
100% |
|
100% |
100% |
|
Realwerk AG |
|
Horgen, Switzerland |
|
Investment Advisor |
|
CHF |
|
100 000 |
|
100% |
100% |
|
100% |
100% |
|
Bellevue Komplementär AG |
|
Küsnacht, Switzerland |
|
Asset Management |
|
CHF |
|
200 000 |
|
100% |
100% |
|
100% |
100% |
Minority shareholders’ equity ownership of BB Pureos Bioventures GP Limited is 1%. Due to the non-materiality of this ownership with respect to the overall Bellevue Group’s equity and comprehensive income, no separate disclosure of minority shareholders has been published on the Group’s financial statements.